Skip to main content

Animations

MJFF Publications

5041 - 5050 of 6564 Results
Title
Year
  • Year
  • 2023
  • 2022
  • 2020
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00592-2
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-022-11371-w
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Characterization of Small-Molecule-Induced Changes in Parkinson's-Related Trafficking via the Nedd4 Ubiquitin Signaling Cascade
    Journal Name: Cell Chemical Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.chembiol.2020.10.008
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease
    Journal Name: Cell Death Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41420-023-01333-0
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Parkin coregulates glutathione metabolism in adult mammalian brain
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01488-4
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00451-x
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-36058-2
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Association of a common genetic variant with Parkinson’s disease is mediated by microglia
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abp8869
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29193
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at 16q11.2 and MAPT H1 loci
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac325
    Citation Count: 65
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.